News
All ranitidine should be discarded, says US drug agency
BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m1390 (Published 06 April 2020) Cite this as: BMJ 2020;369:m1390- Owen Dyer
- Montreal
The heartburn and stomach ulcer drug Zantac (ranitidine) and its generic equivalent should be removed from pharmacy shelves and should be discarded if found at home, the US Food and Drug Administration has said.
The agency cited new findings from its analysis of stockpiled ranitidine, which showed that levels of the probable carcinogen N-nitrosodimethylamine (NDMA) increased over time in the drug during storage.1
New FDA testing, the agency said, had “confirmed …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.